Wednesday, November 25, 2009, 8:49am SGT - The Singapore stock market opens in 11 minutes.
To create a watchlist or portfolio of shares, Register
FINANCE HOME PAGEINVESTINGFINANCE NEWS
    Market:       |  

Valeant Pharmaceuticals International (VRX)

At 5:02AM SGT: 32.85 USD  Up 0.25 (0.77%)  
 MORE ON VRX 
Quotes
HereSummary
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
 VALEANT PHARMA INTL (NYSE:VRX) Delayed quote dataEdit
After Hours: 32.70 Down 0.15 (0.46%) as of 5:03am SGT on 11/25/09
Last Trade:32.85 USD
Trade Time:5:02AM SGT
Change:Up 0.25 (0.77%)
Prev Close:32.60
Open:32.66
Bid:N/A
Ask:N/A
1y Target Est:24.57
Day's Range:32.30 - 32.90
52wk Range:15.64 - 34.44
Volume:489,093
Avg Vol (3m):806,442
Market Cap:2.67B
P/E (ttm):N/A
EPS (ttm):-0.64
Div & Yield:N/A (N/A%)
[Chart]
1d  5d  3m  6m  1y  2y  5y  max 
Use Y! Toolbar to track stocks
 Add VRX to Portfolio   Download Data

 HEADLINES 
•Valeant Pharma begins selling generic IBS drug
AP (Tue 4:46am)
•[$$] Valeant Shares Fall Ill
at Barrons.com (Tue 3:03am)
•Barron's Magazine First Read: Dividends, VRX, DISCA
at Barrons.com (Mon, Nov 23)
•Oceanside Pharmaceuticals Announces Launch of Librax(R) AG
PR Newswire (Mon, Nov 23)
•Valeant may fall if new drug disappoints-Barron's
at Reuters (Mon, Nov 23)
•This Weekend's Barron's: Dividend Paying Stocks; BB&T Is the Banking Belle of the South; Is There Any Hope for Atlantic City
at Barrons.com (Sat, Nov 21)
•[$$] Hot Drug Stock in Need of a Chill Pill
at Barrons.com (Sat, Nov 21)
•Drugmaker Reinvents Itself And Expands Footprint Internationally
Investor's Business Daily (Thu, Nov 19)
•Big Value in Valeant
RealMoney by TheStreet.com (Thu, Nov 12)
•VALEANT PHARMACEUTICALS INTERNATIONAL Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal
EDGAR Online (Wed, Nov 11)
•UBS Research Equity Analyst Picks Top Stocks In Large Cap Biotech Sector
Wall Street Transcript (Wed, Nov 11)
More Headlines for VRX...
 ANALYST 
EPS Est (next year) (Dec-09) :2.04
EPS Est (in 2 years) (Dec-10) :2.27
Avg Rec (current)*:3.6
PEG Ratio:0.93
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

 BUSINESS SUMMARY 
Valeant Pharmaceuticals International, a specialty pharmaceutical company, engages in the development, manufacture, and marketing of a range of pharmaceutical products.

Full Company Profile



Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Search by Company
•Latest News•Singapore Indices